|
SIST EN 12342:2000/kprA1:2009
01-april-2009
Dihalne cevke za uporabo z anestezijskimi aparati in ventilatorji
Breathing tubes intended for use with anaesthetic apparatus and ventilators
Atemschläuche zur Verwendung mit Anästhesie- und Beatmungsgeräten
Tubes (tuyaux) respiratoires destinés à être utilisés avec des appareils d'anesthésie et
des ventilateurs
Ta slovenski standard je istoveten z: EN 12342:1998/prA1
ICS:
11.040.10 Anestezijska, respiratorna in Anaesthetic, respiratory and
reanimacijska oprema reanimation equipment
SIST EN 12342:2000/kprA1:2009 en,fr,de
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.
---------------------- Page: 1 ----------------------
SIST EN 12342:2000/kprA1:2009
---------------------- Page: 2 ----------------------
SIST EN 12342:2000/kprA1:2009
EUROPEAN STANDARD
FINAL DRAFT
EN 12342:1998
NORME EUROPÉENNE
EUROPÄISCHE NORM
prA1
January 2009
ICS 11.040.10
English Version
Breathing tubes intended for use with anaesthetic apparatus and
ventilators
Tubes (tuyaux) respiratoires destinés à être utilisés avec Atemschläuche zur Verwendung mit Anästhesie- und
des appareils d'anesthésie et des ventilateurs Beatmungsgeräten
This draft amendment is submitted to CEN members for unique acceptance procedure. It has been drawn up by the Technical Committee
CEN/TC 215.
This draft amendment A1, if approved, will modify the European Standard EN 12342:1998. If this draft becomes an amendment, CEN
members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for inclusion of this amendment
into the relevant national standard without any alteration.
This draft amendment was established by CEN in three official versions (English, French, German). A version in any other language made
by translation under the responsibility of a CEN member into its own language and notified to the CEN Management Centre has the same
status as the official versions.
CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland,
France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and United Kingdom.
Warning : This document is not a European Standard. It is distributed for review and comments. It is subject to change without notice and
shall not be referred to as a European Standard.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION
EUROPÄISCHES KOMITEE FÜR NORMUNG
Management Centre: rue de Stassart, 36 B-1050 Brussels
© 2009 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN 12342:1998/prA1:2009: E
worldwide for CEN national Members.
---------------------- Page: 3 ----------------------
SIST EN 12342:2000/kprA1:2009
EN 12342:1998/prA1:2009
Contents Page
Foreword . 3
1 Modification to Clause 4 . 4
2 Modification to Clause 12 . 4
3 Modification to Clause 14 . 4
4 Modifications to Clause 15 . 4
5 Addition of Clauses 16 - 18 . 4
6 Modifications to Annex ZA . 5
2
---------------------- Page: 4 ----------------------
SIST EN 12342:2000/kprA1:2009
EN 12342:1998/prA1:2009
Foreword
This document (EN 12342:1998/prA1:2009) has been prepared by Technical Committee
CEN/TC 215 “Respiratory and anaesthetic equipment”, the secretariat of which is held by BSI.
This document is currently submitted to the Unique Acceptance Procedure.
This document has been prepared under a mandate given to CEN by the European
Commission and the European Free Trade Association, and supports essential requirements
of EU Directive(s).
For relationship with EU Directive(s), see informative Annex ZA, which is an integral part of
this document.
3
---------------------- Page: 5 ----------------------
SIST EN 12342:2000/kprA1:2009
EN 12342:1998/prA1:2009
1 Modification to Clause 4
Add the following paragraphs:
"If phthalates are incorporated in parts of the medical devices coming directly or indirectly into
contact with the patient the medical device shall be labelled accordingly.
NOTE Attention is drawn to substances which are carcinog
...